世界中医药
文章摘要
引用本文:刘楠,王婷婷,陈沾,王惠.健脾益肾升阳组方对早期糖尿病肾病的影响[J].世界中医药,2021,(12):.  
健脾益肾升阳组方对早期糖尿病肾病的影响
Effects of Jianpi Yishen Shengyang Formula on Early Diabetic Nephropathy
投稿时间:2019-11-30  
DOI:10.3969/j.issn.1673-7202.2021.12.001
中文关键词:  健脾益肾升阳  早期糖尿病肾病  糖代谢  肾功能  血液流变学  血脂功能  炎症介质  中医症状积分
English Keywords:Jianpi Yishen Shengyang  Early diabetic nephropathy  Glucose metabolism  Renal function  Hemorheology  Blood lipid function  Inflammatory factor  Traditional Chinese medicine symptom integral
基金项目:海南省自然科学基金项目(813242)
作者单位
刘楠,王婷婷,陈沾,王惠 海南医学院第一附属医院肾内科海口570000 
摘要点击次数: 566
全文下载次数: 0
中文摘要:
      目的:探讨健脾益肾升阳组方对早期糖尿病肾病(EDN)的疗效及对糖代谢、肾功能的影响。方法:选取2016年12月至2018年12月海南医学院第一附属医院收治的糖尿病肾病患者124例作为研究对象,按照随机数字表法随机分为对照组和观察组,每组62例。对照组给予西药治疗,观察组在对照组基础上加用健脾益肾升阳组方治疗,均连续治疗8周。观察2组治疗前后肾功能、血糖代谢、血脂功能、血液流变学、炎症介质、中医症状积分的变化。结果:2组治疗后空腹血糖(FBG)、餐后2 h血糖(2 hPG)、糖化血红蛋白(HbA1c)、总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)、24 h尿微量白蛋白排泄率(UAER)、尿β2-微球蛋白(β2-MG)、24 h尿蛋白定量(24 hUPQ)、肌酐(SCr)、尿素氮(BUN)、全血黏度高切、全血黏度低切、血浆黏度、纤维蛋白原、C反应蛋白(CRP)、单核细胞趋化蛋白-1(MCP-1)、巨噬细胞移动抑制因子(MIF)均较治疗前下降,骨密度脂蛋白胆固醇(HDL-C)较治疗前升高(均P<0.05),其中观察组优于对照组(P<0.05)。2组治疗后腰膝酸软、少气懒言、面色晦暗、食少纳呆、肢体水肿麻木较治疗前均降低(均P<0.05),且观察组优于对照组(P<0.05)。结论:健脾益肾升阳组方能保护EDN肾功能,改善糖脂代谢和炎症反应,促进微循环,改善症状,增进疗效。
English Summary:
      To explore the effects of Jianpi Yishen Shengyang Formula on early diabetic nephropathy and its influence on glucose metabolism and renal function.Methods:A total of 124 patients with diabetic nephropathy were selected as the research objects and were randomly divided into a control group and an observation,with 62 cases in each group.The control group was treated with Western medicine,and the combined group was treated with Jianpi Yishen Shengyang group on the basis of Western medicine group.All of them were treated for 8 weeks.The changes of renal function,blood glucose metabolism,blood lipid function,hemorheology,inflammatory factors and traditional Chinese medicine symptom scores were observed before and after treatment.Results:1)Fasting blood glucose(FBG),2 h postprandial blood glucose(2 hPG),glycosylated hemoglobin A1c(HbA1c),total cholesterol(TC),triglycerides(TG),low-density lipoprotein cholesterol(LDL-C),24 h urine microalbumin excretion rate(UAER),urine β2 microglobulin(β2-MG),24 h urine protein quantification(24 hUPQ),creatinine(SCr),urea nitrogen(BUN),whole blood viscosity high shear,whole blood viscosity low-cut,plasma viscosity,fibrinogen,C-reactive protein(CRP),monocyte chemoattractant protein-1(MCP-1),macrophage migration inhibitory factor(MIF) decreased compared with those before treatment,bone density lipoprotein cholesterol(HDL-C) was higher than before treatment(P<0.05),and the observation group was better than the control group(P<0.05).2)After treatment,the 2 groups were treated with lower backs and knees,less gas and lazy speech,dull complexion,less appetite,edema and numbness of the limbs were all lower than before treatment(P<0.05),and the observation group was better than the control group(P<0.05).Conclusion:Jianpi Yishen Shengyang Formula can protect renal function of EDN,improve glucose and lipid metabolism and inflammatory reaction,promote microcirculation,improve symptoms and enhance curative effects.
查看全文  查看/发表评论  下载PDF阅读器